A

Amphastar Pharmaceuticals
D

AMPH

26.405
USD
0.36
(1.36%)
Market Closed
Last updated: · Delayed 15 min
Volume
15,479
EPS
0
Div Yield
-
P/E
16
Market Cap
1,123,214,411
Overview
Related Instruments
ABT
ABT
D
Abbott Laboratories
104.700
1.730(1.68%)
104.800+0.100(+0.10%)
ALGN
ALGN
D
Align Technology
149.380
4.925(3.41%)
148.900-0.480(-0.32%)
BSX
BSX
D
Boston Scientific Corp
44.155
1.150(2.67%)
44.090-0.065(-0.15%)
EW
EW
D
Edwards Lifesciences Corp
88.090
1.640(1.90%)
H
HAE
D
Haemonetics Corp
121.260
0.150(0.12%)
IDXX
IDXX
D
IDEXX Laboratories
547.00
18.28(3.46%)
547.20+0.20(+0.04%)
ISRG
ISRG
D
Intuitive Surgical
427.87
7.62(1.81%)
427.49-0.38(-0.09%)
SYK
SYK
D
Stryker Corp
293.25
11.62(4.13%)
TECH
TECH
D
Bio-Techne Corp
72.540
0.020(0.03%)
TMO
TMO
D
Thermo Fisher Scientific
696.52
23.11(3.43%)
697.03+0.51(+0.07%)
More

Title: Amphastar Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.